Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    When to start and stop hepatitis B treatment: can one set of criteria apply to all patients regardless of age at infection?

    Degertekin B, Lok AS.

    Ann Intern Med. 2007 Jul 3;147(1):62-4. No abstract available. PMID: 17606963 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.
    3.

    Hepatitis B.

    Mohamadnejad M, Malekzadeh R.

    N Engl J Med. 2004 Jun 24;350(26):2719-20. No abstract available. PMID: 15218580 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comments on the EASL practice guidelines for the management of chronic hepatitis B: controversies in interferon-based therapy.

    Janssen HL, Buster EH.

    J Hepatol. 2009 Jul;51(1):224-6. Epub 2009 Mar 12. No abstract available. PMID: 19410322 [PubMed - indexed for MEDLINE]Related articles

    5.

    EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy.

    Papatheodoridis GV, Manolakopoulos S.

    J Hepatol. 2009 Jul;51(1):226-7. Epub 2009 Mar 12. No abstract available. PMID: 19410321 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment]

    Veldhuijzen IK, Mostert MC, Niesters HG, Richardus JH, de Man RA.

    Ned Tijdschr Geneeskd. 2008 Jun 21;152(25):1426-30. Dutch. PMID: 18624006 [PubMed - indexed for MEDLINE]Related articles

    7.

    HBeAg negative chronic hepatitis B with persistently normal serum transaminase and low HBV DNA can cause significant liver disease.

    Al-Mahtab M, Rahman S, Khan M; Md. Kamal, Al Mamun A.

    Indian J Gastroenterol. 2007 Nov-Dec;26(6):297. No abstract available. PMID: 18431019 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Induce treatment of recombinant interferon alpha-1b for chronic hepatitis B and its therapeutic efficiency]

    Xu Z, Wang C, Li Sq S, Huang Yq Y.

    Zhonghua Gan Zang Bing Za Zhi. 2002 Feb;10(1):33. Chinese. No abstract available. PMID: 11856499 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression.

    Yoo BC, Kim JH, Kim TH, Koh KC, Um SH, Kim YS, Lee KS, Han BH, Chon CY, Han JY, Ryu SH, Kim HC, Byun KS, Hwang SG, Kim BI, Cho M, Yoo K, Lee HJ, Hwang JS, Kim YS, Lee YS, Choi SK, Lee YJ, Yang JM, Park JW, Lee MS, Kim DG, Chung YH, Cho SH, Choi JY, Kweon YO, Lee HY, Jeong SH, Yoo HW, Lee HS.

    Hepatology. 2007 Oct;46(4):1041-8.PMID: 17647293 [PubMed - indexed for MEDLINE]Related articles

    10.

    Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.

    Liaw YF.

    Hepatology. 2007 Sep;46(3):947; author reply 947-9. No abstract available. PMID: 17705263 [PubMed - indexed for MEDLINE]Related articles

    11.

    ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.

    ter Borg MJ, Hansen BE, Bigot G, Haagmans BL, Janssen HL.

    J Clin Virol. 2008 Jun;42(2):160-4. Epub 2008 Mar 24.PMID: 18359663 [PubMed - indexed for MEDLINE]Related articles

    12.

    Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

    Marcellin P, Chang TT, Lim SG, Sievert W, Tong M, Arterburn S, Borroto-Esoda K, Frederick D, Rousseau F.

    Hepatology. 2008 Sep;48(3):750-8.PMID: 18752330 [PubMed - indexed for MEDLINE]Related articles

    13.

    Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.

    Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK.

    J Viral Hepat. 2008 Jun;15(6):434-41. Epub 2008 Jan 9.PMID: 18194171 [PubMed - indexed for MEDLINE]Related articles

    14.

    Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants.

    Wu IC, Shiffman ML, Tong MJ, Marcellin P, Mondou E, Frederick D, Snow-Lampart A, Sorbel J, Rousseau F, Chang TT.

    Clin Infect Dis. 2008 Nov 15;47(10):1305-11.PMID: 18840078 [PubMed - indexed for MEDLINE]Related articles

    15.

    Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.

    Akhan SC, Yulugkural Z, Vahaboglu H.

    Chemotherapy. 2007;53(6):402-6. Epub 2007 Oct 12.PMID: 17934260 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.

    Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ.

    Hepatology. 2007 Oct;46(4):1057-70.PMID: 17654702 [PubMed - indexed for MEDLINE]Related articles

    17.

    [The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers]

    Olut AI, Ozünlü H, Bozdağ H, Ozkalay N.

    Mikrobiyol Bul. 2007 Jul;41(3):429-33. Turkish. PMID: 17933254 [PubMed - indexed for MEDLINE]Related articles

    18.

    Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B.

    Stornaiuolo G, Stanzione M, Brancaccio G, Cuomo G, Precone V, Di Biase S, Felaco FM, Piccinino F, Gaeta GB.

    World J Gastroenterol. 2007 Nov 14;13(42):5642-7.PMID: 17948940 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    What is the best end point for hepatitis B treatment?

    Lai CL, Yuen MF.

    Ann Intern Med. 2008 Apr 1;148(7):560; author reply 560-1. No abstract available. PMID: 18378952 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.

    Yang YF, Zhao W, Zhong YD, Yang YJ, Shen L, Zhang N, Huang P.

    Antiviral Res. 2008 Feb;77(2):136-41. Epub 2007 Nov 26.PMID: 18078676 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data